missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ENPP7 (aa 377-456) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (40%), Rat (40%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55120 (PA5-55120. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ENPP7 converts sphingomyelin to ceramide. ENPP7 also has phospholipase C activity toward palmitoyl lyso-phosphocholine. ENPP7 does not appear to have nucleotide pyrophosphatase activity.
Specifications
Specifications
| Accession Number | Q6UWV6 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 339221 |
| Name | Human ENPP7 (aa 377-456) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | alkaline sphingomyelin phosphodiesterase; alkaline sphingomyelinase; Alk-SMase; ectonucleotide pyrophosphatase/phosphodiesterase 7; ectonucleotide pyrophosphatase/phosphodiesterase family member 7; E-NPP 7; ENPP7; E-NPP7; Gm254; Intestinal alkaline sphingomyelinase; NPP7; NPP-7; sphingomyelinase, intestinal alkaline; UNQ3077/PRO9912 |
| Common Name | ENPP7 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction